Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib cost?The expiration date of the key patent for guselkumab?Drugpatentwatch market analysis industry today?Brenzavvy discontinuation?Dabrafenib and trametinib price?
See the DrugPatentWatch profile for humira
Prices for Humira vary a lot by country, dosing, and insurance coverage. Here’s a quick gist for the United States, which is where pricing details are most often asked: - Typical list price (before discounts/insurance) for a common US regimen (40 mg every other week, i.e., about 80 mg per month) is roughly in the range of $7,000–$8,000 per month. - Your actual out‑of‑pocket cost can be much lower if you have insurance, a manufacturer co-pay program, or qualify for patient assistance. Some people pay only a small amount or nothing with the right coverage. - If you’re uninsured, the cash price can still be in that same general range, but it varies by pharmacy. Things that change the price: - Dosing schedule (monthly total mg can differ if you’re on a different regimen) - Country and local price controls - Insurance plan, formulary placement, and deductibles - Availability of biosimilars (e.g., Cyltezo, Abrilada) and how your plan covers them If you want a more precise estimate, tell me: - Your country - Your dosing plan (for example, 40 mg every other week, or another schedule) - Whether you have insurance and what kind (private, Medicare/Medicaid) - If you’re looking for the cash price or your expected copay I can then tailor the estimate and also point you to potential cost‑reduction options (insurance routing, manufacturer assistance programs, or biosimilar alternatives).
Other Questions About Humira :